Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. [electronic resource]
Producer: 20041028Description: 133-42 p. digitalISSN:- 1023-3830
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Arthritis, Rheumatoid -- drug therapy
- Collagen -- immunology
- Female
- Hyperalgesia -- drug therapy
- Male
- Mice
- Mice, Inbred DBA
- Phthalazines -- pharmacology
- Pyridines -- pharmacology
- Rats
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.